
Divis Laboratories Ltd
Past performance
About Divis Laboratories Ltd Divi's Laboratories Ltd., established in 1990, is a leading global pharmaceutical company specializing in the production of Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceuticals, with a strong focus on exports across 100 countries. The company supports innovator pharma firms through custom synthesis for patented products and has a diverse portfolio of approximately 160 products across various therapeutic areas. With six manufacturing facilities, including a newly established Unit-III in Kakinada, and two overseas subsidiaries in the USA and Switzerland, Divi's Laboratories maintains a robust international presence.
The company has consistently expanded its operations and capabilities, evidenced by significant investments in special economic zones (SEZs), brownfield projects, and modernization efforts. Despite challenges such as regulatory inspections and the COVID-19 pandemic, Divi's has continued to enhance its manufacturing capacities and waste treatment infrastructure. The firm's strategic focus on custom synthesis and backward integration underscores its commitment to meeting the growing demands of the generic and big pharma sectors.
Performance overview
